s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
D
Exempt (Private) Offering
Filed
Wednesday, March 23, 2022
Accession number
0001567619-22-007387
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header